New Study: Antioxidants May Prevent Breast Cancer!

November 17, 2010 Leave a Comment

GOOD NEWS FOLKS: a recent study in Asian Pacific Journal of Cancer Prevent suggests that exogenous antioxidants like vitamine E, vatimin C and beta-carotene may help reduce the risk of developing breast cancer.  The study indicates that reducing “oxidative stress” could play a role in stopping breast cancer from developing in the first place! The Cellular Health Foundation has long discussed the value of eliminating oxidative stress and controlling or fighting free radicals with, not just … [Read more...]

US Government Study: Immunocal for Lung Cancer!

September 15, 2010 Leave a Comment

The US government is now actively recruiting participants for a Phase III Clinical Trial of Immunocal.  This study will determine if Immunocal is effective in treating lung cancer.  (Click here to view the official posting by the government on their public website ClinicalTrials.gov.) Immunotec has already completed a clinical study that proves Immunocal stops weight loss in lung cancer patients and increases survival rates, but this new study, sponsored by the NIH (National Institute of … [Read more...]

Can Immunocal help her?

May 6, 2010 1 Comment

I'm Not Sick, I Just Have Cancer!" The story of 10 year old Jazmine as told by her Mother Anna Maria Jazmine's mother and father love all three of their beautiful daughters but Jazmine holds a special place in their hearts.  Her mother says now, "I feel like a little girl with a new doll..." She hasn't always felt that way.  You see, Jazmine has been diagnosed with a brain tumor, a rare cancer, in fact, there are SEVEN different kinds of cancer in this little girl's head.  The doctor … [Read more...]

Clinical Trial by US Government – Lung Cancer & Immunocal

August 2, 2009 Leave a Comment
Dr. Jimmy Gutman, MD

Immunotec Announces an Independent, Clinical Research Initiative at Beaumont Hospitals' Hospital's Community Clinical Oncology Program (CCOP). This Pilot Study is Supported by the Moffitt Cancer Center CCOP Research Base, which is funded by NCI. Posted : Sat, 01 Aug 2009 13:21:24 GMT Author : IMMUNOTEC INC. MONTREAL, Aug. 1 /PRNewswire-FirstCall/ - Immunotec Inc. (TSX-V: IMM) announced today that the U.S. Food and Drug Administration has approved an investigator-held IND (#105,140) for the … [Read more...]